BR9811780A - Método de aumento de volume ósseo usando agonistas seletivos fp não ocorrendo naturalmente - Google Patents
Método de aumento de volume ósseo usando agonistas seletivos fp não ocorrendo naturalmenteInfo
- Publication number
- BR9811780A BR9811780A BR9811780-7A BR9811780A BR9811780A BR 9811780 A BR9811780 A BR 9811780A BR 9811780 A BR9811780 A BR 9811780A BR 9811780 A BR9811780 A BR 9811780A
- Authority
- BR
- Brazil
- Prior art keywords
- bone volume
- agonists
- selective
- naturally occurring
- volume increase
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 210000000988 bone and bone Anatomy 0.000 title abstract 3
- 208000020084 Bone disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patente de Invenção: <B>"MéTODO DE AUMENTO DE VOLUME óSSEO USANDO AGONISTAS SELETIVOS FP NãO OCORRENDO NATURALMENTE"<D>. A presente invenção refere-se a novos métodos de aumento de volume ósseo compreendendo a administração de um agonistas FP seletivo não ocorrendo naturalmente a um sujeito em necessidade de tal tratamento. Esta invenção além disso refere-se a um método de tratamento ou prevenção de distúrbios ósseos compreendendo a administração de um agonistas FP seletivo não ocorrendo naturalmente a um sujeito em necessidade de tal tratamento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5830697P | 1997-09-09 | 1997-09-09 | |
| PCT/US1998/018338 WO1999012551A1 (en) | 1997-09-09 | 1998-09-04 | Method of increasing bone volume using non-naturally-occurring fp selective agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9811780A true BR9811780A (pt) | 2000-09-12 |
Family
ID=22015996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9811780-7A BR9811780A (pt) | 1997-09-09 | 1998-09-04 | Método de aumento de volume ósseo usando agonistas seletivos fp não ocorrendo naturalmente |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6156799A (pt) |
| EP (1) | EP1045694A1 (pt) |
| JP (1) | JP2001515864A (pt) |
| KR (1) | KR20010023840A (pt) |
| CN (1) | CN1269721A (pt) |
| AR (1) | AR013479A1 (pt) |
| AU (1) | AU739275B2 (pt) |
| BR (1) | BR9811780A (pt) |
| CA (1) | CA2303800A1 (pt) |
| CO (1) | CO4980882A1 (pt) |
| HU (1) | HUP0004581A2 (pt) |
| ID (1) | ID24827A (pt) |
| IL (1) | IL134760A0 (pt) |
| NO (1) | NO20001171L (pt) |
| PE (1) | PE119099A1 (pt) |
| PL (1) | PL339288A1 (pt) |
| SK (1) | SK3412000A3 (pt) |
| TR (1) | TR200000662T2 (pt) |
| WO (1) | WO1999012551A1 (pt) |
| ZA (1) | ZA988228B (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3385900A (en) * | 1999-03-05 | 2000-09-21 | Procter & Gamble Company, The | Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives |
| ES2233351T3 (es) * | 1999-03-05 | 2005-06-16 | Duke University | Analogos de prostaglandinas c-16 fp selectivas insaturadas. |
| NZ513825A (en) * | 1999-03-05 | 2001-09-28 | Procter & Gamble | C 16 unsaturated FP-selective prostaglandins analogs |
| EP1158969A2 (en) * | 1999-03-05 | 2001-12-05 | The Procter & Gamble Company | Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume |
| CA2303060A1 (en) * | 1999-04-14 | 2000-10-14 | United States Gear Corporation | Towed vehicle brake controller |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US6904123B2 (en) | 2000-08-29 | 2005-06-07 | Imaging Therapeutics, Inc. | Methods and devices for quantitative analysis of x-ray images |
| CA2419483A1 (en) | 2000-08-29 | 2002-03-07 | Osteonet.Com, Inc. | Methods and devices for quantitative analysis of x-ray images |
| US7467892B2 (en) | 2000-08-29 | 2008-12-23 | Imaging Therapeutics, Inc. | Calibration devices and methods of use thereof |
| US8639009B2 (en) | 2000-10-11 | 2014-01-28 | Imatx, Inc. | Methods and devices for evaluating and treating a bone condition based on x-ray image analysis |
| US7660453B2 (en) | 2000-10-11 | 2010-02-09 | Imaging Therapeutics, Inc. | Methods and devices for analysis of x-ray images |
| US8000766B2 (en) | 2001-05-25 | 2011-08-16 | Imatx, Inc. | Methods to diagnose treat and prevent bone loss |
| BR0211364A (pt) * | 2001-07-23 | 2004-07-13 | Ono Pharmaceutical Co | Composição farmacêutica para tratamento de doenças associadas com redução na massa óssea compreendendo o agonista ep4 como componente ativo |
| ES2360604T3 (es) * | 2001-07-23 | 2011-06-07 | Ono Pharmaceutical Co., Ltd. | Remedios para enfermedades con pérdida de masa osea que tienen como ingrediente activo agonistas de ep4. |
| CN1642503A (zh) * | 2002-02-07 | 2005-07-20 | 拉特格斯·新泽西州立大学 | 用于药物送递的治疗聚酐化合物 |
| US7840247B2 (en) | 2002-09-16 | 2010-11-23 | Imatx, Inc. | Methods of predicting musculoskeletal disease |
| US8965075B2 (en) | 2002-09-16 | 2015-02-24 | Imatx, Inc. | System and method for predicting future fractures |
| JP2007524438A (ja) | 2003-03-25 | 2007-08-30 | イメージング セラピューティクス，インコーポレーテッド | 放射線画像処理技術における補償の方法 |
| US8290564B2 (en) | 2003-09-19 | 2012-10-16 | Imatx, Inc. | Method for bone structure prognosis and simulated bone remodeling |
| CA2539487A1 (en) * | 2003-09-19 | 2005-03-31 | Imaging Therapeutics, Inc. | Method for bone structure prognosis and simulated bone remodeling |
| CA2580726A1 (en) | 2004-09-16 | 2006-03-30 | Imaging Therapeutics, Inc. | System and method of predicting future fractures |
| WO2008034101A2 (en) * | 2006-09-15 | 2008-03-20 | Imaging Therapeutics, Inc. | Method and system for providing fracture/no fracture classification |
| US8939917B2 (en) | 2009-02-13 | 2015-01-27 | Imatx, Inc. | Methods and devices for quantitative analysis of bone and cartilage |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4621100A (en) * | 1981-09-25 | 1986-11-04 | The Upjohn Company | Treatment of osteoporosis with prostaglandins |
| WO1993015767A1 (en) * | 1992-02-05 | 1993-08-19 | Merck & Co., Inc. | Implant therapy for bone growth stimulation |
| US5310759A (en) * | 1992-08-12 | 1994-05-10 | Bockman Richard S | Methods of protecting and preserving connective and support tissues |
| US5409911A (en) * | 1992-09-11 | 1995-04-25 | Merck & Co., Inc. | Prostaglandin analog for treating osteoporosis |
| US5747660A (en) * | 1995-11-06 | 1998-05-05 | The University Of Colorado | Nucleic acid encoding prostaglandin F2α receptor regulatory protein |
| US5703108A (en) * | 1996-02-28 | 1997-12-30 | Pfizer Inc. | Bone deposition by certain prostaglandin agonists |
-
1998
- 1998-09-04 KR KR1020007002516A patent/KR20010023840A/ko not_active Ceased
- 1998-09-04 EP EP98944718A patent/EP1045694A1/en not_active Withdrawn
- 1998-09-04 TR TR2000/00662T patent/TR200000662T2/xx unknown
- 1998-09-04 PL PL98339288A patent/PL339288A1/xx unknown
- 1998-09-04 WO PCT/US1998/018338 patent/WO1999012551A1/en not_active Ceased
- 1998-09-04 SK SK341-2000A patent/SK3412000A3/sk unknown
- 1998-09-04 IL IL13476098A patent/IL134760A0/xx unknown
- 1998-09-04 ID IDW20000637A patent/ID24827A/id unknown
- 1998-09-04 CN CN98808885A patent/CN1269721A/zh active Pending
- 1998-09-04 JP JP2000510448A patent/JP2001515864A/ja not_active Withdrawn
- 1998-09-04 AU AU92192/98A patent/AU739275B2/en not_active Ceased
- 1998-09-04 US US09/148,105 patent/US6156799A/en not_active Expired - Fee Related
- 1998-09-04 HU HU0004581A patent/HUP0004581A2/hu unknown
- 1998-09-04 CA CA002303800A patent/CA2303800A1/en not_active Abandoned
- 1998-09-04 BR BR9811780-7A patent/BR9811780A/pt not_active IP Right Cessation
- 1998-09-08 AR ARP980104483A patent/AR013479A1/es unknown
- 1998-09-09 PE PE1998000854A patent/PE119099A1/es not_active Application Discontinuation
- 1998-09-09 CO CO98051811A patent/CO4980882A1/es unknown
- 1998-09-09 ZA ZA988228A patent/ZA988228B/xx unknown
-
2000
- 2000-03-07 NO NO20001171A patent/NO20001171L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999012551A1 (en) | 1999-03-18 |
| IL134760A0 (en) | 2001-04-30 |
| CN1269721A (zh) | 2000-10-11 |
| US6156799A (en) | 2000-12-05 |
| PL339288A1 (en) | 2000-12-04 |
| CA2303800A1 (en) | 1999-03-18 |
| AU9219298A (en) | 1999-03-29 |
| NO20001171D0 (no) | 2000-03-07 |
| AU739275B2 (en) | 2001-10-11 |
| CO4980882A1 (es) | 2000-11-27 |
| JP2001515864A (ja) | 2001-09-25 |
| PE119099A1 (es) | 2000-02-03 |
| ID24827A (id) | 2000-08-24 |
| SK3412000A3 (en) | 2000-12-11 |
| NO20001171L (no) | 2000-05-09 |
| KR20010023840A (ko) | 2001-03-26 |
| AR013479A1 (es) | 2000-12-27 |
| HUP0004581A2 (hu) | 2001-05-28 |
| TR200000662T2 (tr) | 2000-07-21 |
| EP1045694A1 (en) | 2000-10-25 |
| ZA988228B (en) | 1999-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9811780A (pt) | Método de aumento de volume ósseo usando agonistas seletivos fp não ocorrendo naturalmente | |
| AP2001002129A0 (en) | 5HT1 receptor agonists and metoclopramide for the treatment of migrane. | |
| BG102726A (en) | Combined therapy for osteoporosis | |
| MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
| PT867178E (pt) | Utilizacao de agonistas nao alostericos de gaba para o tratamento de desordens do sono | |
| WO2000038665A3 (en) | Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | |
| BR9806118A (pt) | Processos para tratamento de pigmentação de pele | |
| EP0935963A3 (en) | The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders | |
| WO1999036064A3 (en) | Methods of treating tardive dyskinesia and other movement disorders | |
| BG105256A (en) | Muscarinic agonists and antagonists | |
| DE69711078D1 (de) | Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz | |
| MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
| HUP0101528A3 (en) | The treatment of fertility disorders use of lhrh antagonists and antioestrogens in | |
| EP1383529A4 (en) | METHOD FOR THE TREATMENT OF EYES AND SQUATING TISSUES WITH THYMOSINE 4 (T 4), ANALOGUE, ISOFORMS AND OTHER DERIVATIVES | |
| AP1896A (en) | The method of treating cancer | |
| GB2331301B (en) | Galanin | |
| YU26401A (sh) | Oralni koncentrat sertralina | |
| CO5150204A1 (es) | Metodo de aumentar el volumen oseo que comprende la administracion de un agonista fp selectivo que no ocurre naturalmente y un agonista ep1 selectivo que no ocurre naturalmente a un sujeto que requiere tal tratamiento | |
| BR0005319A (pt) | Tratamento combinado para depressão e ansiedade | |
| WO2000051585A3 (en) | Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume | |
| CO5150237A1 (es) | Metodos de aumentar el volumen oseo que comprenden la administracion de un agonista fp selectivo que no ocurre naturalmente y un compuesto de antiresorcion a un sujeto que requiere tal tratamiento | |
| UA20075A (uk) | Спосіб діагhостуваhhя та лікуваhhя стійких фуhкціоhальhих зміщеhь hижhьої щелепи | |
| AU2002358267A8 (en) | Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 | |
| EP1517912A4 (en) | METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145 | |
| EE04951B1 (et) | R-(+)-alfa-(2,3-dimetoksfenl)-1-[2-(4-fluorofenl)etl]-4-piperidiinmetanooli kasutamine unehirete raviks |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A,5A,6A,7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1888 DE 13/03/2007. |